How The Global Fund Plans To Raise US$ 14 Billion To Meet Its Goals 11/02/2019 by Patralekha Chatterjee NEW DELHI, India -- Since its creation in 2002, the Global Fund to Fight AIDS, Tuberculosis and Malaria has been an extraordinarily successful financing instrument in global health. It says it has saved 27 million lives as of the end of 2017 and reduced the number of deaths caused by AIDS, TB and malaria each year by one-third since 2002 in the countries where it invests. Now the Global Fund director has some ideas to increase funding to carry on the fight. Continue reading -> New High-Tech System Against Falsified Medicines Goes Live In Europe 08/02/2019 by William New A ground-breaking new high-tech patient safety system to catch falsified medicines in the supply chain in Europe went into effect today, allowing prescription medicines to undergo verification for authenticity before reaching patients. Continue reading -> High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 by William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 by Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 by Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 by Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 by Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 by David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> WHO Members Unite To Support Universal Health Coverage; US Blasts Abortion 05/02/2019 by Catherine Saez With a united voice that World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations. The United States, however, dissociated itself from language it thought gave a permissive view of abortion. Continue reading -> WHO Benchmarking Tool Made “More Transparent” In Evaluating Regulatory Authorities 05/02/2019 by David Branigan Over the past year, the World Health Organization (WHO) has rolled out the latest version of its benchmarking tool for evaluating progress of national regulatory authorities towards meeting WHO quality assurance targets. This benchmarking tool applies a more transparent and systematic approach than previous versions, and was developed through “extensive” consultation with member states and the public. Continue reading -> Posts navigation Older postsNewer posts
New High-Tech System Against Falsified Medicines Goes Live In Europe 08/02/2019 by William New A ground-breaking new high-tech patient safety system to catch falsified medicines in the supply chain in Europe went into effect today, allowing prescription medicines to undergo verification for authenticity before reaching patients. Continue reading -> High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 by William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 by Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 by Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 by Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 by Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 by David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> WHO Members Unite To Support Universal Health Coverage; US Blasts Abortion 05/02/2019 by Catherine Saez With a united voice that World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations. The United States, however, dissociated itself from language it thought gave a permissive view of abortion. Continue reading -> WHO Benchmarking Tool Made “More Transparent” In Evaluating Regulatory Authorities 05/02/2019 by David Branigan Over the past year, the World Health Organization (WHO) has rolled out the latest version of its benchmarking tool for evaluating progress of national regulatory authorities towards meeting WHO quality assurance targets. This benchmarking tool applies a more transparent and systematic approach than previous versions, and was developed through “extensive” consultation with member states and the public. Continue reading -> Posts navigation Older postsNewer posts
High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 by William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 by Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 by Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 by Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 by Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 by David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> WHO Members Unite To Support Universal Health Coverage; US Blasts Abortion 05/02/2019 by Catherine Saez With a united voice that World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations. The United States, however, dissociated itself from language it thought gave a permissive view of abortion. Continue reading -> WHO Benchmarking Tool Made “More Transparent” In Evaluating Regulatory Authorities 05/02/2019 by David Branigan Over the past year, the World Health Organization (WHO) has rolled out the latest version of its benchmarking tool for evaluating progress of national regulatory authorities towards meeting WHO quality assurance targets. This benchmarking tool applies a more transparent and systematic approach than previous versions, and was developed through “extensive” consultation with member states and the public. Continue reading -> Posts navigation Older postsNewer posts
The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 by Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 by Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 by Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 by Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 by David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> WHO Members Unite To Support Universal Health Coverage; US Blasts Abortion 05/02/2019 by Catherine Saez With a united voice that World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations. The United States, however, dissociated itself from language it thought gave a permissive view of abortion. Continue reading -> WHO Benchmarking Tool Made “More Transparent” In Evaluating Regulatory Authorities 05/02/2019 by David Branigan Over the past year, the World Health Organization (WHO) has rolled out the latest version of its benchmarking tool for evaluating progress of national regulatory authorities towards meeting WHO quality assurance targets. This benchmarking tool applies a more transparent and systematic approach than previous versions, and was developed through “extensive” consultation with member states and the public. Continue reading -> Posts navigation Older postsNewer posts
WHO Recommends Cannabis Be Reclassified In UN Convention On Narcotic Drugs 07/02/2019 by Elaine Ruth Fletcher The World Health Organization has recommended to the UN Secretary General that cannabis and cannabis resin be removed from Schedule IV of the 1961 Single Convention on Narcotic Drugs – a classification of drugs with “particularly dangerous properties”, including narcotics such as fentanyl, heroin and other opioids. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 by Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 by Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 by David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> WHO Members Unite To Support Universal Health Coverage; US Blasts Abortion 05/02/2019 by Catherine Saez With a united voice that World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations. The United States, however, dissociated itself from language it thought gave a permissive view of abortion. Continue reading -> WHO Benchmarking Tool Made “More Transparent” In Evaluating Regulatory Authorities 05/02/2019 by David Branigan Over the past year, the World Health Organization (WHO) has rolled out the latest version of its benchmarking tool for evaluating progress of national regulatory authorities towards meeting WHO quality assurance targets. This benchmarking tool applies a more transparent and systematic approach than previous versions, and was developed through “extensive” consultation with member states and the public. Continue reading -> Posts navigation Older postsNewer posts
Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 by Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 by Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 by David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> WHO Members Unite To Support Universal Health Coverage; US Blasts Abortion 05/02/2019 by Catherine Saez With a united voice that World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations. The United States, however, dissociated itself from language it thought gave a permissive view of abortion. Continue reading -> WHO Benchmarking Tool Made “More Transparent” In Evaluating Regulatory Authorities 05/02/2019 by David Branigan Over the past year, the World Health Organization (WHO) has rolled out the latest version of its benchmarking tool for evaluating progress of national regulatory authorities towards meeting WHO quality assurance targets. This benchmarking tool applies a more transparent and systematic approach than previous versions, and was developed through “extensive” consultation with member states and the public. Continue reading -> Posts navigation Older postsNewer posts
WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 by Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 by David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> WHO Members Unite To Support Universal Health Coverage; US Blasts Abortion 05/02/2019 by Catherine Saez With a united voice that World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations. The United States, however, dissociated itself from language it thought gave a permissive view of abortion. Continue reading -> WHO Benchmarking Tool Made “More Transparent” In Evaluating Regulatory Authorities 05/02/2019 by David Branigan Over the past year, the World Health Organization (WHO) has rolled out the latest version of its benchmarking tool for evaluating progress of national regulatory authorities towards meeting WHO quality assurance targets. This benchmarking tool applies a more transparent and systematic approach than previous versions, and was developed through “extensive” consultation with member states and the public. Continue reading -> Posts navigation Older postsNewer posts
New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 by David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> WHO Members Unite To Support Universal Health Coverage; US Blasts Abortion 05/02/2019 by Catherine Saez With a united voice that World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations. The United States, however, dissociated itself from language it thought gave a permissive view of abortion. Continue reading -> WHO Benchmarking Tool Made “More Transparent” In Evaluating Regulatory Authorities 05/02/2019 by David Branigan Over the past year, the World Health Organization (WHO) has rolled out the latest version of its benchmarking tool for evaluating progress of national regulatory authorities towards meeting WHO quality assurance targets. This benchmarking tool applies a more transparent and systematic approach than previous versions, and was developed through “extensive” consultation with member states and the public. Continue reading -> Posts navigation Older postsNewer posts
WHO Members Unite To Support Universal Health Coverage; US Blasts Abortion 05/02/2019 by Catherine Saez With a united voice that World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations. The United States, however, dissociated itself from language it thought gave a permissive view of abortion. Continue reading -> WHO Benchmarking Tool Made “More Transparent” In Evaluating Regulatory Authorities 05/02/2019 by David Branigan Over the past year, the World Health Organization (WHO) has rolled out the latest version of its benchmarking tool for evaluating progress of national regulatory authorities towards meeting WHO quality assurance targets. This benchmarking tool applies a more transparent and systematic approach than previous versions, and was developed through “extensive” consultation with member states and the public. Continue reading -> Posts navigation Older postsNewer posts
WHO Benchmarking Tool Made “More Transparent” In Evaluating Regulatory Authorities 05/02/2019 by David Branigan Over the past year, the World Health Organization (WHO) has rolled out the latest version of its benchmarking tool for evaluating progress of national regulatory authorities towards meeting WHO quality assurance targets. This benchmarking tool applies a more transparent and systematic approach than previous versions, and was developed through “extensive” consultation with member states and the public. Continue reading -> Posts navigation Older postsNewer posts